Edgemont Pharmaceuticals
Company intelligence

Edgemont Pharmaceuticals Company Intelligence, Company Record Signals

Domain trust
Corroborated domain alignment
Domain evidence combines website domain, social profile, company email sample, and support email alignment; raw email addresses are hidden.
Company email sample
1 official-domain emails
AeroLeads source data includes 1 email record across 1 domain; raw addresses are hidden. 1 match edgemontpharma.com.
Funding signal
Debt financing
Historical funding signal; last round Jun 1, 2015; funding amount 5.0M; 2 total rounds.
Social audience
103
Audience size from company social follower data.

AeroLeads company intelligence

Edgemont Pharmaceuticals company signal intelligence

Evidence from AeroLeads company records and related company graph.

High confidence
Intelligence completeness
Basic intelligence record
3 of 11 major intelligence groups are available for this company.
Social followers
103
Audience size from company social data.
Funding signal
Debt financing
Last round jun 1, 2015, funding amount 5.0m, 2 total rounds.

Data methodology

AeroLeads renders only source-backed fields for this company page.

3 source groups
Company record Related company graph Company signal fields
Blank source fields are omitted
Related companies are ordered deterministically
Structured data uses aggregate counts only

Intelligence completeness

3 of 11 major intelligence groups are available for this company.

3 / 11 groups
Basic intelligence record 27.3%
Contactability Domain confidence Market and peer context

Domain trust signals

Domain confidence for edgemontpharma.com is based on website domain, social profile, company email sample, and support email alignment.

55 / 100
Corroborated domain alignment Corroborated domain evidence

Domain evidence combines website domain, social profile, company email sample, and support email alignment; raw email addresses are hidden.

Website domain
edgemontpharma.com
The official website domain is available from the company source record.
Social profile
LinkedIn organization page
A LinkedIn organization page is present for this company record.
Company email sample
1 official-domain source email records
Company-level email source records include official-domain coverage; raw addresses are hidden.
Support email alignment
Official-domain support email
The support email channel aligns with the official company domain; raw addresses are hidden.

AeroLeads coverage snapshot

Contact channel mix
Multi-channel contact coverage
Visible profile or company source data includes email and phone channels.
Contact evidence confidence
Mapped contact-channel evidence
Visible profile or company source data includes email and phone channels.
Company support channels
Email and phone
Company record includes support email and phone contact channels.
Domain confidence
Corroborated domain alignment
Domain confidence for edgemontpharma.com is based on website domain, social profile, company email sample, and support email alignment.
Contact data safety
Corroborated privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Company signal breadth
Two-signal company record
Company-level signals include social audience and funding.
Company momentum score
Limited company momentum score
Momentum score blends historical funding signal and peer position from AeroLeads company and profile evidence.
Audience density
Low audience density
103 followers against 31 employee estimate, about 3.30 followers per estimated employee.
Funding recency
Historical funding signal
Last funding round is 133 months before the Jun 2026 source update.
Market specificity
Peer-informed market profile
2 related peer industry clusters available.
Peer industry clusters
2
Industries represented by related company records.
Related companies
10
Company graph links available for comparison.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 3 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Peer benchmark confidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Peer position benchmark
Employee-scale peer position benchmark
Peer-position benchmark shows employee scale above 50% of 8 comparable related peers.
Peer comparison matrix
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Intelligence signal groups
5
AeroLeads signal groups available for this company.

Market focus signals

Primary industry
Biotechnology Research
Market specificity
Peer-informed market profile
2 related peer industry clusters available.
Market evidence tier
Mapped market evidence
Market evidence combines 3 classification signals from categories and related peer industries.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 3 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Top peer industry
Pharmaceutical Manufacturing
66% of 10 related peer industry signals.
Peer benchmark evidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Size position
Near peer median size
4 related employee-estimated peers are higher and 4 are lower.
Peer graph strength
Benchmark-ready peer graph
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.
Benchmark dimensions: peer graph strength, size benchmark, and size position.
Categories
Biotechnology Research
Product-market keyword evidence
Limited market keywords
Keyword evidence comes from 1 source field group: Category.
Product-market keyword evidence tier: Limited product-market keyword evidence. Product-market keyword evidence combines 1 unique market keyword and 1 source field group (1 category).
Biotechnology Research · Category
Related peer industries
Peer-industry evidence tier: High-confidence peer-industry evidence. Peer-industry evidence combines 9 related companies, 2 peer-industry clusters, and top peer industry Pharmaceutical Manufacturing at 66.7%.
Pharmaceutical Manufacturing 6 peers
66.7% of related peer industries
Biotechnology Research 3 peers
33.3% of related peer industries

Company signals

Company signal breadth
Two-signal company record
Company-level signals include social audience and funding.
Corroborated company record evidence: Company record evidence combines 2 source-backed company signal types: social audience and funding.
Social audience
103
Followers in the company source record.
Social audience evidence tier: Limited social-audience evidence. Social audience evidence uses 103 followers from source field social_followers.
Audience density
Low audience density
103 followers against 31 employee estimate, about 3.30 followers per estimated employee.
Audience-density evidence tier: Limited audience-density evidence. Audience-density evidence combines 103 social followers, 31 employee estimate, and 3.30 followers per estimated employee.
Funding
Debt financing
5.0M · Jun 1, 2015 · 2 total rounds
Funding evidence tier: High-confidence funding evidence. Funding evidence combines round type Debt financing, funding amount 5.0M, last round date Jun 1, 2015, 2 total rounds, and historical funding signal from structured company source fields.
Historical funding signal: Last funding round is 133 months before the Jun 2026 source update.

Contactability signals

Contact channel mix
Multi-channel contact coverage
Visible profile or company source data includes email and phone channels.
Contact evidence tier
Mapped contact-channel evidence
Visible profile or company source data includes email and phone channels.
Contact data safety
Corroborated privacy-safe contact intelligence
AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
Aggregate signals
3
Channel coverage
Email and phone aggregate coverage
Evidence groups
3
Corroborated contact-safety evidence: Contact-safety evidence combines company email sample, support channels, and official-domain email evidence; public schema uses aggregate variables only.
Aggregate-only contact schema: Dataset variables use counts, rates, channel labels, freshness bands, and domain-alignment metrics instead of raw contact values.
Company support channels
Email and phone
Company record includes support email and phone contact channels.
Support channel evidence tier: Dual-channel support evidence. Support evidence combines email and phone channels from the company record; raw contact values are hidden.
Company email sample
Limited company email sample
AeroLeads source data includes 1 email record across 1 domain; raw addresses are hidden. 1 match edgemontpharma.com.
Source email evidence tier: Limited source email evidence. Source email evidence combines 1 unique source email record, 1 domain, 1 matching edgemontpharma.com, and 100.0% official-domain rate.

Explore related pages

Related company intelligence:

Company source details

Address
Austin, Texas, United States
Phone signal
Phone signal available; raw number hidden
Email signal
Email signal available; raw address hidden
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
edgemontpharma.com
HQ
Austin, Texas
Funding
5.0M
Related companies
Xeris Pharmaceuticals, Inc., XBiotech USA, Inc., Savara Inc., Lumos Pharma, Aeglea BioTherapeutics, Curtana Pharmaceuticals, Cao Pharmaceuticals Inc., United Pharmatek, LLC., Affirmed Pharma, Inc., Pirochem International LLC.

Edgemont Pharmaceuticals Questions